A Comparison of Planar Sensitivity and Spatial Resolution among Different Collimators and Energy Windows on <sup>223</sup>Ra Imaging-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Comparison of Planar Sensitivity and Spatial Resolution among Different Collimators and Energy Windows on ²²³Ra Imaging

Published:2017 Issue:11 Volume:73 Page:1132-1139
ISSN:0369-4305
Container-title:Japanese Journal of Radiological Technology
language:en
Short-container-title:Nippon Hoshasen Gijutsu Gakkai Zasshi

Author:

Umeda Takuro¹,Miyaji Noriaki¹,Nakazawa Shuto¹,Miwa Kenta²,Wagatsuma Kei³,Motegi Kazuki¹,Takiguchi Tomohiro¹,Koizumi Mitsuru¹

Affiliation:

1. Department of Nuclear Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research

2. School of Health Science, International University of Health and Welfare

3. Research Team for Neuroimaging, Tokyo Metropolitan Institute of Gerontology

Publisher

Japanese Society of Radiological Technology

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jjrt/73/11/73_2017_JSRT_73.11.1132/_pdf

Reference26 articles.

1. 1) D’Huyvetter M, Xavier C, Caveliers V, et al. Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer. Expert Opin Drug Deliv 2014; 11(12): 1939–1954.

2. 2) Lee DY, Li KC. Molecular theranostics: a primer for the imaging professional. AJR Am J Roentgenol 2011; 197 (2): 318–324.

3. 3) Ersahin D, Doddamane I, Cheng D. Targeted radionuclide therapy. Cancer (Basel) 2011; 3(4): 3838–3855.

4. 4) Shirley M, McCormack PL. Radium-223 dichloride: a review of its use in patients with castration-resistant prostate cancer with symptomatic bone metastases. Drugs 2014; 74(5): 579–586.

5. 5) Parker C, Finkelstein SE, Michalski JM, et al. Efficacy and safety of radium-223 dichloride in symptomatic castration-resistant prostate cancer patients with or without baseline opioid use from the phase 3 ALSYMPCA Trial. Eur Urol 2016; 70(5): 875–883.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3